INS and glioma: Among the clinical factors, insulin use was identified as a significant factor for the association between WC and the risk of glioma (adjusted HR [95% CI]; 0.740 [0.485, 1.130] in insulin users vs. 1.174 [1.043, 1.322] in non-insulin users, P for interaction = 0.034) (Table 3).